Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Naloxone Could Prevent 20,000 Drug Overdose Deaths in U.S.: WHO Report November 4, 2014 Russell Maas Add Your Comments A report published by the World Health Organization (WHO) suggests that the availability of the counter opioid drug naloxone could prevent tens of thousands of overdose deaths each year. In a WHO report issued this week, the organization calls on countries around the world to increase the availability of the over-the-counter drug naloxone in an effort to combat increasing overdose-related deaths. Naloxone is a generic drug that has been available for more than 40 years and is designed to counter overdoses of heroin and prescription opioids such as hydrocodone, oxycodone, codeine, and tramadol. The drug is considered safe among government health officials and has a low risk of serious side effects. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The WHO claims that an estimated 20,000 lives could be saved each annually in the United States if the drug were more prevalent. While naloxone does not necessarily cure a person following a near overdose, it plays an important role in buying professionals time to implement an intervention, said Rosanna Cunningham, Minister for Community Safety and Legal Affairs. Scotland Success Leads WHO To Recommend Widescale Use WHO’s article explains how important the drug could be to society if it were more readily available in families or communities where drug overdoses are common. The first country to experiment with a public program for the drug was Scotland, which saw an significant spike is overdoses in 2009, reaching 545 drug-related deaths. Starting in 2010, Scotland implemented the “Take Home Naloxone” program that allowed the drug to become accessible after specialist training to people at risk of opioid overdose with hope to spread awareness to their close friends and family. According to a report by the National Health Service, approximately 6,500 Naloxone kits were issued to people in Scotland between 2012 and 2013. The report indicated that the number of drug related deaths fell from 581 in 2011 to 526 by the end of 2013. Officials are not entirely sure that the decrease of drug related deaths can be attributed to the Naloxone kits being distributed to areas prone to overdoses. However, the number of overdoses in Scotland finally began to decrease after being on the rise for three consecutive years. WHO’s report explains the impact the drug could have on countries such as the United States, China, and Russia; which all are among the leaders in opioid related deaths from overdose. Globally, an estimated 69,000 people die from opioid overdose per year. Those who overdose are individuals who misjudge the dose or their own tolerance for the opioid, and their death is often witnessed by a family member who would be nearby to administer Naloxone. Over the last 40 years naloxone has been used intravenously, which could deter some patients from using it. However, Naloxone is now available in a new intranasal spray, which is more affordable and could work within 2-3 minutes and carry minimal side effects. As of now, the nasal form is primarily used among emergency service providers, such as ambulance departments. On September 17, the U.S. Centers for Disease Control and Prevention (CDC) released a report that found prescription drug overdose deaths in the United States nearly quadrupled between 1999 and 2011. Dr. Holly Hedegaard, lead author of the report and injury epidemiologist at the National Center for Health Statistic, said misuse and abuse of prescription drugs, specifically painkillers, impacted more than 40,000 people, with more than 40% of those involving opioid analgesics or narcotic painkillers resulting in intentional or unintentionaloverdose deathsin 2011. In 2012, the CDC released a report which indicated prescription drug overdoses have reached epidemic proportions. Prescription drug overdoses kill someone in the U.S every 19 minutes. The number of deaths attributed to painkillers have exceeded those linked to cocaine and heroin combined since 2003. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Drug Abuse, Drug Overdose, Hydrocodone, Naloxone, Oxycontin More Lawsuit Stories Lawyers Call for Hair Relaxer Cancer Lawsuit To Be Set for Trial January 28, 2026 Syngenta Settles Paraquat Parkinson’s Lawsuit as Trial Was Set To Begin in Philadelphia January 28, 2026 Otis Elevator Lawsuit Alleges Malfunction Caused Elevator To Descend Uncontrolled January 28, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawyers Call for Hair Relaxer Cancer Lawsuit To Be Set for Trial (Posted: today) Ahead of a case management conference this week, hair relaxer cancer lawsuit lawyers have asked a federal judge to set a date for the first bellwether trial. MORE ABOUT: HAIR RELAXER LAWSUITPresentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (01/05/2026)Hair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025) Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: yesterday) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025) Abbott Eterna Spinal Cord Stimulator Lawsuit Filed Over Lead Migration, Device Malfunction (Posted: 2 days ago) A spinal cord stimulator lawsuit claims an Abbott Eterna device failed after only two months due to lead migration. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Spinal Cord Stimulator Lawsuit Claims Lead and Battery Problems Led to Multiple Revision Surgeries (10/22/2025)Medtronic Spinal Cord Stimulator Lawsuit Alleges Device Worsened Pain (04/30/2025)FDA Tells Doctors To Conduct Trial Stimulation Test Before Using Spinal Cord Stimulators (09/04/2020)
Syngenta Settles Paraquat Parkinson’s Lawsuit as Trial Was Set To Begin in Philadelphia January 28, 2026
Lawyers Call for Hair Relaxer Cancer Lawsuit To Be Set for Trial (Posted: today) Ahead of a case management conference this week, hair relaxer cancer lawsuit lawyers have asked a federal judge to set a date for the first bellwether trial. MORE ABOUT: HAIR RELAXER LAWSUITPresentations on How Hair Relaxers Cause Cancer Will Be Heard by MDL Judge This Week (01/05/2026)Hair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep (12/10/2025)Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (11/13/2025)
Bard PowerPort Settlement Talks May Heat Up as First Bellwether Trials Approach in 2026 (Posted: yesterday) As Bard PowerPort litigation nears its first bellwether trials, the prospect of major jury verdicts over catheter fracture, migration and infection injuries is increasing speculation that settlement talks may intensify, following earlier claims that Becton Dickinson says were resolved in about 18 months before consolidation into a federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (01/15/2026)Cook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)
Abbott Eterna Spinal Cord Stimulator Lawsuit Filed Over Lead Migration, Device Malfunction (Posted: 2 days ago) A spinal cord stimulator lawsuit claims an Abbott Eterna device failed after only two months due to lead migration. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Spinal Cord Stimulator Lawsuit Claims Lead and Battery Problems Led to Multiple Revision Surgeries (10/22/2025)Medtronic Spinal Cord Stimulator Lawsuit Alleges Device Worsened Pain (04/30/2025)FDA Tells Doctors To Conduct Trial Stimulation Test Before Using Spinal Cord Stimulators (09/04/2020)